The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
Aim. To characterize the plasma levels of vascular endothelial growth factor (VEGF) in type 1 diabetes mellitus (T1D) and its relation to both present and historical metabolic control and microvascular complications. Methods. Plasma levels of VEGF and routine clinical parameters were analyzed in 115...
Saved in:
Main Authors: | Kailash Singh, Stellan Sandler, Daniel Espes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2017/6192896 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes
by: Daniel Espes, et al.
Published: (2014-01-01) -
Proinflammatory Cytokines Increase Vascular Endothelial Growth Factor Expression in Alveolar Epithelial Cells
by: James P. Maloney, et al.
Published: (2015-01-01) -
Assessment of Serum Vascular Endothelial Growth Factor Levels in Pregnancy-Induced Hypertension Patients
by: Vibha Tandon, et al.
Published: (2017-01-01) -
Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
by: Toshiaki Kubota, et al.
Published: (2012-01-01) -
Comparison between Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Levels in Rhegmatogenous Retinal Detachment
by: Andi Muhammad Ichsan, et al.
Published: (2021-01-01)